Results 51 to 60 of about 288,544 (208)

An analysis of sociodemographic, dietary and environmental determinants of allergic rhinitis and atopic eczema symptoms among adolescents in Cape Town, South Africa : findings from the International Study of Asthma and Allergies in Childhood (ISAAC) [PDF]

open access: yes, 2011
Most analyses of International Study of Asthma and Allergies in Childhood (ISAAC) data in developing countries have suggested an increase over time in 12-month prevalence of rhinitis and eczema symptoms amongst adolescents. The objective of this study is
Dearham, Astrid Chrisilda
core   +1 more source

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo‐Controlled, Phase III Trial

open access: yesAllergy, EarlyView.
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian   +18 more
wiley   +1 more source

Quality of life in allergic rhinitis - children’s and their parents’ perspective in polish urban and rural population

open access: yesHealth and Quality of Life Outcomes, 2020
Background Allergic rhinitis is a common chronic condition in the paediatric population. No reports regarding the quality of life in children with allergic rhinitis in the Polish population have been found in the available literature.
Hanna Sikorska-Szaflik   +1 more
doaj   +1 more source

Rhinophototherapy, an alternative treatment of allergic rhinitis: Systematic review and meta-analysis

open access: yesBrazilian Journal of Otorhinolaryngology, 2021
Introduction: Allergic rhinitis is a chronic inflammatory disease of the nasal mucosa, mediated by immunoglobulin E, affecting 1 in 6 individuals. The treatment aims at attaining symptomatic control with minimal side effects, a requirement for new ...
Tatyana Machado Ramos Costa   +5 more
doaj   +1 more source

Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient‐Recorded Symptoms: The @IT.2020 Project

open access: yesAllergy, EarlyView.
Daily prospective symptom reports from participants in this multicentre observational study were compared to retrospective (last 12 months) reports based on ARIA clinical questionnaire. Retrospective reports substantially underestimated, and to a lesser extent overestimated, symptom frequency compared to e‐Diary prospective reports. Since retrospective
Stephanie Dramburg   +56 more
wiley   +1 more source

Allergic Rhinitis Systematic Review Shows the Trends in Prevalence in Children and Adolescents in Greece since 1990

open access: yes, 2023
Allergic rhinitis is the most common immune disorder worldwide, affecting approximately 10–40% of the general population. It is characterized by an inflammatory response of the nasal mucosa following exposure to non-infectious, inhaled, and ...
Konstantinos Douros   +4 more
core   +1 more source

Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis

open access: yesMonaldi Archives for Chest Disease, 2005
Background: The Link between allergic rhinitis and asthma is well known. Bronchial hyperreactivity (BHR) may be present in rhinitics. The present study is aimed at evaluating a large group of subjects suffering from allergic rhinitis alone to investigate
I. Cirillo   +6 more
doaj   +1 more source

Efficacy and safety of a new mometasone furoate nasal spray formulation in patients with acute rhinosinusitis: a randomized clinical trial

open access: yesItalian Journal of Medicine, 2022
Common inflammatory airway disorders, such as seasonal and perennial allergic rhinitis, acute sinusitis, and nasal polyposis, can have a significant impact on patient health and quality of life.
Yasir Mehmood   +3 more
doaj   +1 more source

Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy

open access: yesAllergy, EarlyView.
We conducted a two stage SCIT trial with GNR‐127 containing a recombinant fusion protein consisting of Bet v 1 and Mal d 1‐derived peptides fused to PreS from HBV. Stage 1 identified two safe maximum tolerated doses (40 μg and 80 μg). In the following Stage 2, five preseasonal injections were well tolerated, induced dose‐dependent allergen‐specific IgG,
Musa R. Khaitov   +43 more
wiley   +1 more source

When perennial rhinitis worsens: rhinolith mimicking severe allergic rhinitis [PDF]

open access: yesBMJ Case Reports, 2014
Allergic rhinitis is one of the most common causes of nasal obstruction, but other diseases need to be considered particularly when the clinical course is getting worse. We present a patient with known mild persistent allergic rhinitis due to house dust mites who experienced progressive worsening of nasal obstruction with associated hyposmia and ...
HEFFLER, Enrico Marco   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy